<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Neuroblastoma &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/neuroblastoma/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 06 Jan 2026 16:52:47 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Neuroblastoma &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>CNTNAP2 Identified as Tumor Suppressor in Neuroblastoma</title>
		<link>https://bioengineer.org/cntnap2-identified-as-tumor-suppressor-in-neuroblastoma/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 06 Jan 2026 16:52:21 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[CNTNAP2]]></category>
		<category><![CDATA[Neuroblastoma]]></category>
		<category><![CDATA[Pediatric cancer]]></category>
		<category><![CDATA[Tumor suppressor gene]]></category>
		<category><![CDATA[whole-genome sequencing]]></category>
		<guid isPermaLink="false">https://bioengineer.org/cntnap2-identified-as-tumor-suppressor-in-neuroblastoma/</guid>

					<description><![CDATA[In a groundbreaking study published in the Journal of Translational Medicine, researchers Liu, Y., Zhao, J., and Wang, K., among others, have unveiled significant findings that could reshape our understanding of neuroblastomas, particularly the role of the CNTNAP2 gene in this aggressive cancer. Neuroblastomas are among the most common pediatric cancers, and their high-risk variants [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">314167</post-id>	</item>
	</channel>
</rss>
